News

Allergan plc, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative…
Read More...

Perrigo Company plc, a leading global provider of Quality Affordable Healthcare Products, today announced it has completed the divestiture of its rights to the royalty stream from…
Read More...

Orexigen Therapeutics, Inc. announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Bruno Farmaceutici S.p.A. (Bruno) have executed a distributorship…
Read More...

Allergan plc, a leading global pharmaceutical company and Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative…
Read More...

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, today…
Read More...

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), has issued a positive opinion, recommending an…
Read More...

ShangPharma, a leading life science partnering organization providing high-quality and cost-effective drug development and discovery services, technology, and investment for the…
Read More...

Elbit Imaging Ltd. announced that it was informed by Gamida Cell Ltd., an indirect associate of the Company, that the orphan drug designation, which has been granted by the European…
Read More...

C4 Therapeutics (C4T) and Calico today announced a five-year collaboration to discover, develop, and commercialize therapies for treating diseases of aging, including cancer. Under…
Read More...

BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it has acquired Agalimmune Ltd., a private UK-based company with an…
Read More...

Intec Pharma Ltd., a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill™ platform technology, announces the initiation of a…
Read More...

Moleculin Biotech, Inc., a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The…
Read More...

Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor protein p53, today announced a…
Read More...

Pierre Fabre, the second largest privately held pharmaceutical company in France, and H-Immune SAS, an emerging biotechnology company focused on developing first in class…
Read More...

argenx, a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today…
Read More...

Pulmatrix a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases announced that it has received a key patent from the…
Read More...

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced…
Read More...

Novaliq, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced…
Read More...

Mallinckrodt plc, a leading specialty pharmaceutical company, announced today it has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in…
Read More...

Bristol-Myers Squibb Company and CytomX Therapeutics, Inc., a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, today announced an…
Read More...